Broadcaster Jeon Hyun-moo faces police scrutiny over a nine-year-old TV scene featuring an IV drip administered in a car. His ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

TV personality Jun Hyun-moo’s agency denied allegations Friday that Jun received illegal medical treatment after a clip from ...

The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

Click here for more articles b. Following allegations that comedian Park Na-rae received illegal medical treatment from a ...

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...

I once turned back from visiting a nearby internal medicine clinic during lunchtime due to a cold. The waiting room was ...

Starting with comedian Park Na-rae, while broadcasters such as height and short-spoken sunshine are engulfed in 'Jusaimo Gate ...

FDA approves Johnson & Johnson's Rybrevant Faspro for EGFR lung cancer and expands TRUFILL use for chronic subdural hematoma ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...